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Abstract 
 
A study was performed to examine the administration of flunixin meglumine 
(FM; an inhibitor of prostaglandin F2α) following artificial insemination on pregnancy 
rates of lactating dairy cattle.  Jersey and Holstein cows (n=106) were randomly assigned 
to receive intravenously either FM (2.2 mg/kg BW) or saline (SAL; 1 mL/23 kg BW).  
Cows were randomly allotted to treatment by lactation number, bovine somatotropin 
administration, breed, BW, days in milk, milk production, and 305 ME milk production.  
Study was performed from September through April and all cows were milked twice 
daily.  Following estrous synchronization (cloprostenol, 500 µg im), cows were 
artificially inseminated 12 ± 6 h after the onset of estrus was detected utilizing electronic 
monitoring.  Administration of FM or SAL was administered 5 d ± 12 h following 
artificial insemination.  Animals underwent verification of pregnancy 28-35 d following 
artificial insemination using transrectal ultrasonography by an individual blinded to 
treatment.  Pregnancy was determined by the presence or absence of an embryo with a 
heartbeat.  Pregnancy data were analyzed using CRD Mixed ANOVA Analysis.  
Administration of FM following artificial insemination did not improve pregnancy rates 
in lactating dairy cows (FM, 37 vs SAL, 31.4%; P > 0.10).  In conclusion, treatment with 
flunixin meglumine did not improve pregnancy rates when administered following 
artificial insemination in lactating dairy cows.    
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1.  Introduction 
 
 Reproductive failure in dairy cows is a problem that has increased over the last 
three decades and continues to plague the modern dairy producer (reviewed by Lucy, 
2001).  When dairy cattle suffer reproductive difficulties, they encounter increased days 
open, a term that refers to the time during which an animal is not pregnant (reviewed by 
Lucy, 2001).  An increase in days open can result in a loss of income.  The average dairy 
cow costs the producer up to $4.00 per each day open after 85 days postpartum (Britt, 
1975).  In order to avoid this monetary loss, the producer must reestablish pregnancy 
approximately 60-90 days postpartum.  However, many factors, such as an animal’s 
stress level and nutrition, can lead to the failure of reestablishing and maintaining 
pregnancy during this time period. 
 Lactating dairy cows endure continuous stress due to two - and, in some cases, 
three - milkings every day.  Heat stress due to ambient temperature is another factor that 
tends to hinder pregnancy (reviewed by De Rensis and Scaramuzzi, 2003).  Management 
practices that use stimulating growth hormones (Cole et al., 1991; reviewed by Dohoo et 
al., 2003) and highly concentrated nutrition can negatively affect days open in dairy cows 
(O’Callaghan et al., 2000).  Since failure to establish and maintain pregnancy in an 
animal results in monetary loss for the agricultural industry, researchers must determine 
other means by which reproduction can be made more successful.  One course of action 
is to control the prostaglandins produced during establishment of pregnancy.  
 Prostaglandins are hormones that are released by most mammalian cells (Bito, 
1975).  They are involved in inflammation, pain and fever production, control of blood 
vessel tone, luteolysis, and blood clotting (Nett et al., 1976; Seibert et al., 1994; Blatteis 
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and Sehic, 1997).  The study of luteolysis is central to understanding how to maintain 
pregnancy.  Prostaglandin F2alpha (PGF2α) is capable of lysing the corpus luteum (CL) on 
the mammalian ovary (reviewed by Bazer et al., 1993).  The CL is responsible for the 
production of progesterone, the hormone that maintains pregnancy (Fields, 1991).   
Prostaglandin F2α not only lyses the corpus luteum, but it also provides a dangerous 
environment for the embryo.  Studies indicate the presence of high concentrations of 
PGF2α around the embryo at days 5-8 of development have a negative effect on continued 
development (Schrick et al., 1993; Breuel et al., 1993; Seals et al., 1998; Lemaster et al., 
1999; Hockett et al, 2004; Scenna et al., 2004a). 
 Research has explored effects of PGF2α on the embryo at early stages of 
development.  Studies have been performed in which PGF2α was administered on days 5 
through 8 following artificial insemination.  These studies involved cows that were 
supplemented with progestogen, and the results indicated a reduction in pregnancy rates 
and the development of retarded embryos (Buford et al., 1996; Hockett et al., 2004; Seals 
et al., 1998; Lemaster et al., 1999).  These results indicate a direct and/or indirect effect 
of PGF2α on embryonic survival in the cow.    Schrick and coworkers (1993) reported a 
negative correlation between embryo quality and high uterine luminal concentrations of 
PGF2α.  Breuel and coworkers (1993) reported detrimental effects on 8-cell rat embryos 
when cultured with PGF2α.  The culture of these 8-cell embryos with PGF2α caused a 
decrease in the number of embryos reaching morula, blastocyst, and expanded blastocyst 
stages (Breuel et al., 1993).    
 The failure for an embryo to advance to morula and blastocyst stages results in 
embryonic death.  Data presented by Breuel (1993) agree with the indications made by 
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Schrick (1993) that increased concentrations of PGF2α in the uterine lumen may 
contribute to embryonic mortality.   Scenna and coworkers (2004a) reported that PGF2α 
had a negative effect on the continued development of both in vitro and in vivo-derived 
embryos.  Reduced blastocyst formation was seen in 16-32 cell stage embryos that were 
in vitro derived.  A reduction in blastocyst formation was not seen in in vivo-derived 
embryos, but a reduction in hatching blastocysts was observed.  Extensive studies have 
indicated that PGF2α does in fact have an effect on embryo quality and survival; 
therefore, these studies indicate that PGF2α may be causing early embryonic mortality.  
Premature release of uterine luminal concentrations of PGF2α can be the result of several 
factors such as heat stress (Putney et al.,1989; Maylayer et al., 1990), nutrition (reviewed 
by Butler, 1998), mastitis (Hockett et al., 2000), and manipulation of the reproductive 
tract during artificial insemination and embryo transfer (Wann and Randel, 1990; Velez 
et al., 1991; Scenna et al., 2004b). 
 Artificial insemination is a management tool utilized by the majority of cattle 
producers in animal agriculture.  It is a process that allows an individual to maximize the 
genetic potential of an animal by choosing from several hundred sires.  Studies have 
shown that manipulation of the reproductive tract during artificial insemination or 
embryonic transfer causes an increase in PGF2α concentrations (Wann and Randel, 1990; 
Scenna et al., 2004b).  Manipulation of the reproductive tract, and insertion of the 
artificial insemination gun into the cow’s reproductive tract, results in an inflammatory 
response.  Flunixin meglumine is a known inhibitor of certain enzymes involved in 
inflammatory responses (Odensvik et al., 1989).  The inhibition of these enzymes causes 
a block of 15-ketodihydro-PGF2α, the main metabolite of PGF2α (Odensvik et al., 1995; 
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Konigsson et al., 2003).  Administration of flunixin meglumine at the time of embryo 
transfer has been shown to increase pregnancy rates in cows (Scenna et al., 2004b).  The 
act of transferring an embryo in a cow involves all actions involved in artificial 
insemination. The administration of flunixin meglumine following artificial insemination, 
and its effects on pregnancy rates, will be addressed by this thesis.   
 The specific objective of the continued work in this field is to discover more 
efficient means of establishing and maintaining pregnancy in dairy and beef cattle; 
therefore, lowering the cost of production.  The specific aim of this study is to increase 
reproductive performance by decreasing embryonic mortality through the use of 
prostaglandin inhibitors.  It is hypothesized that administration of a prostaglandin 
inhibitor will improve reproductive efficiency in lactating dairy cattle due to the stress of 
high milk production and factors associated with high milk production.  This task will be 
attempted by administering flunixin meglumine at day 5 following artificial insemination.  
A decrease in embryonic mortality will increase pregnancy rates, thus allowing for a 
better reproductive efficiency.  A higher reproductive efficiency will decrease the number 
of days open of an individual animal, and save the average dairy producer approximately 
$60,000 per year.  The savings of the average producer calculates into millions of dollars 
for animal agriculture in the nation.  A lower production cost allows for a better and more 
consistent product for the public.  
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2.  Literature Review 
2.1  Reproductive Inefficiency in Dairy Cattle 
 The dairy industry has changed dramatically in the past decades.  Milk production 
per cow has increased as a result of better management, nutrition, and genetic selection.  
Dairy farms in the United States have grown into larger operations.  Nearly 30% of the 
cows in the United States are on farms with 500 cows or more (reviewed by Lucy, 2001).  
A shift towards more productive cows has been associated with poorer reproductive 
performance (Pryce et al., 1999).  Cows with the highest milk production tend to have the 
highest incidence of infertility, but other factors may be affecting reproduction (Butler, 
2000).   
 The need for more milk production per cow can be explained by an increase in 
demand for dairy products.  A growing population has demanded more dairy products 
and forced the producer towards more production per cow.  This growing trend toward 
more production per cow has led to a smaller number of dairy cows meeting a high 
demand.  Animals are managed so that pregnancy must be established during a highly 
stressful time for the animal.  Animals are usually inseminated around day 60-75 of 
lactation, the time when peak production is reached and animals are beginning to recover 
from a loss of body weight (reviewed by Lucy, 2001).  Lifetime milk production of an 
individual cow depends on whether the animal can become pregnant and return for 
another lactation.  Pregnancy drives the lifetime productivity of a dairy animal because 
parturition results in lactation.  Declining fertility in the dairy industry is probably a 
combination of physiological and management factors that have an additive effect on 
reproductive efficiency (reviewed by Lucy, 2001). 
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 The decline in reproductive efficiency has been documented in several 
publications.  Butler performed a review (1998) and reported a decline in first-service 
conception rates from approximately 65% in 1951 to 40% in 1996 on farms studied in 
New York.  Casida et al. (1961) reported that cows artificially inseminated at observed 
estrus in the 1950s typically reported conception rates of 55%.  Dransfield et al. (1998) 
performed a review of the literature to report conception rates of 45% for inseminations 
at observed estrus.  The fact that conception rates have decreased by such a significant 
percentage indicates that a problem may exist with establishment of pregnancy in dairy 
cattle in the United States.   
 Dairy cattle in the United States are not the only cattle experiencing a decline in 
reproductive efficiency.  Similar decreases have been reported for first-service 
conception rates in Ireland (Roche et al., 2000), Australia (Macmillan et al., 1996) and 
the United Kingdom (Royal et al., 2000).  A decline in European countries may be due to 
a move toward selection for high milk yield United States genetics, without changing 
local management and feeding practices (reviewed by Lucy, 2001).  Nevertheless, poor 
reproductive efficiency is a worldwide problem affecting the dairy industry (reviewed by 
Lucy, 2001). 
 The extent of reproductive decline is poorly documented because many dairy 
producers do not maintain adequate reproductive records.  The Dairy Herd Improvement 
Association (DHIA) is an association that collects herd records for milk production, 
reproduction, and nutrition.  An individual producer must willfully participate and pay for 
the services that DHIA offers.  Records on every herd participating in the program are 
kept in Raleigh, NC, in the Dairy records Management Systems (DRMS).  Silvia et al. 
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(1998) reviewed the DHIA records for dairy producers in Kentucky.  Silvia reported an 
increase in services per conception of 1.62 to 2.91 from 1972 to 1996.  Lucy (2001) 
observed increases in services per conception, days open, and days to first insemination 
in 143 dairy herds continuously enrolled in the DHIA record system from 1970 to 1999.  
Lucy (2001) reported that the greatest decline in reproductive efficiency of these herds 
occurred after the mid-1980s.  The data obtained are not necessarily a good 
representation of the US dairy herds because producers must voluntarily enroll in the 
dairy testing program.  Nevertheless, data indicate that a reproductive efficiency problem 
has developed over the past decades. 
 The decline of reproductive efficiency has been established through DHIA 
records and personal communication between producers and veterinarians nationwide.  
The cause of this decline is usually associated with increased milk production and a 
combination of other management factors.  The 2001 USDA National Agricultural 
Statistics service showed that nearly 30% of all dairy cows in the United States were 
found on farms of 500 or more cows.  The number of herds with fewer than 200 cows has 
decreased, while the number of farms with greater than 200 cows has increased.  These 
statistics indicate that the current trend is a consolidation of the dairy industry into large 
farms with more cows (reviewed by Lucy, 2001). 
 In order for a producer to expand their lactating herd, the producer must purchase 
or maintain replacement animals.  Stahl et al. (1999) reported that pregnant heifers or 
first-lactation cows are often used to expand a dairy.  First-lactation cows have a lower 
energy balance because they consume less, and they require energy for lactation and 
growth.  Lower energy balance in first lactation cows has been associated with delayed 
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intervals to first ovulation (Lucy et al., 1992).  This delayed ovulation in animals with 
lower energy balance may explain why the first lactation has been identified as a risk for 
conception failure (Loeffler et al., 1999).  Many herds have a large percentage of first-
lactation cows because culling practices usually lead to the removal of older cows.  
Reduced reproductive efficiency in first-lactation cows may be the reason producers have 
seen an overall reduction in reproduction during this expansion era.   
 Inbreeding is another factor that may influence reproductive performance in an 
expanding dairy industry.  The breeding of dairy cows in the past few decades has moved 
towards maximizing milk production.  The use of artificial insemination allows a 
producer to use a desired bull many times.  Artificial insemination can increase the 
occurrence of inbreeding if a producer is not careful with their matings.  Hermas et al. 
(1987) concluded that a 1% increase of inbreeding led to a 0.17 increase in services per 
conception, a 2-day increase in days open, and a 3.3% decrease in conception rate.  If 
these estimates are correct, inbreeding could be the sole cause of an increase of 7 days 
open, 0.6 increase in services per conception, and a 12% decrease in conception rate 
since 1980 (Hansen, 2000).  Present levels of inbreeding are approximately 5% (Hansen, 
2000).  Hansen (2000) predicts that levels of inbreeding will reach 10% by the year 2020.  
Inbreeding is an aspect of the growing dairy industry that must be monitored, but it is 
probably not the only reason for decreased reproductive efficiency. 
 Numerous factors could have contributed to the decline in reproductive 
performance in the dairy industry over the past two decades.  Unfortunately, few research 
programs in the United States concentrate on reproduction in the dairy cow.  This fact 
leads to many assumptions about why a decrease in reproductive performance has been 
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experienced.  Further research is needed to identify why reproduction has declined, and 
what can be done to improve the reproductive efficiency of the dairy cow.   
2.2  Embryonic Development 
2.2.1  The sperm and oocyte fusion 
 The development of an embryo occurs over several different stages:  fertilization, 
1-cell stage, 2-cell stage, 4-cell stage, 8-cell stage, 16-cell stage, morula, blastocyst, 
expanded blastocyst, hatching blastocyst, maternal recognition of pregnancy, and 
placental attachment (reviewed by Bazer et al., 1993).  One must understand each of 
these stages in order to identify problems that may cause embryonic mortality. 
 Fertilization requires three steps to take place: sperm migration through the 
reproductive tract, sperm attachment and migration through the zona-pellucida, and 
fusion of sperm and oocyte membranes.  Sperm first travels through the vagina, cervix, 
and uterus, where it begins preparation for fertilization.  Sperm preparation, known as 
sperm capacitation, begins in the uterus and is completed in the isthmus of the oviduct 
(reviewed by Bazer et al., 1993).   
 A sperm cell basically consists of the head, mid-piece, and tail.  The head is the 
area in which the chromatin is carried.  Chromatin comprises the DNA of a haploid 
nucleus (reviewed by Bazer et al., 1993).  A caplike structure called the acrosome covers 
the anterior end of the head.  This acrosome cap carries enzymes that will be used to 
penetrate the membranes of the zona pellucida (Tulsiani et al., 1998).  Energy for the 
motility of the sperm cell is generated in the mid-piece. The purpose of the sperm tail is 
providing a means of travel to the oocyte, and penetrating the oocyte.  The oocyte 
consists of several layers that the sperm must penetrate: the cumulus oophorus, zona 
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pellucida, perivitelline space, and vitelline membrane.  Physical properties of the sperm 
and oocyte allow each of them to successfully merge and complete the act of fertilization 
(reviewed by Bazer et al., 1993). 
   All physical aspects of the sperm and oocyte contribute to the penetration and 
fusion of genomic properties of each.  The presence of a sperm triggers events that 
change the membrane potential of the oocyte.  Binding of the sperm to the zona pellucida 
is a receptor mediated event (Tulsiani et al., 1998).  The specific sperm receptor has been 
identified as the ZP3 glycoprotein (Bleil and Wasserman, 1980).  Only an intact 
acrosome can bind to this receptor.  Once the sperm binds to the zona pellucida, the 
sperm binding protein stimulates events that lead to the fusion of the plasma membrane 
and the acrosomal membrane.  The acrosomal membrane of a sperm cell contains a 
lysosome that forms around the anterior portion of the nucleus.  This lysosome contains 
enzymes that are responsible for digesting the zona pellucida so entry of the sperm may 
occur.  The tail movement of the sperm is also used for entry into the zona pellucida.  
Once the sperm has penetrated the zona pellucida, it moves into the vitelline space and 
contacts the vitelline membrane.  Following fusion with the oocyte, the sperm nuclear 
envelope breaks down.  Chromatin from the sperm and oocyte migrate to the center of the 
ovum, and the chromosomes of each intertwine.  These two haploid cells now produce a 
diploid cell which contains the genomic make up of the offspring.  These steps conclude 
the act of fertilization and lead to the development of a 1-cell embryo (reviewed by Bazer 
et al., 1993). 
 The development of the embryo continues at the one-cell stage and is taken 
through several stages until a fetus is formed.  The joining of the two haploid cells, or 
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chromatin, will come together to form a diploid cell.  It is at this stage that the embryo is 
considered to be one-cell.  The one-cell embryo will rapidly divide into 2, 4, 8, and 16 
cells through a process called mitosis.  The dividing of the cells is referred to as cleavage 
division.  Mitotic division results in daughter cells, in which each cell receives the full 
assortment of chromosomes.  Cells that are undergoing cleavage are known as 
blastomeres.  Following the formation of a 16-cell embryo, the blastomeres begin to form 
tight junctions with one another.  These blastomeres flatten on each other to form a 
rounded embryo and an internal cell mass.  Surface microvilli are also formed and 
become asymmetrically positioned in a process called polarization (reviewed by Bazer et 
al., 1993).   
 The combined processes of flattening and polarization are referred to as 
compaction (reviewed by Bazer et al., 1993).  The formation of tight junctions and 
compaction result in the separation of cells.  One population of cells produces the inner 
cell mass and gives rise to the embryo and fetus.  The other cells produce the 
trophectoderm.  The trophectoderm acquires the ability to transport nutrients and water 
from the uterine environment to the blastocoelic cavity.  The continued accumulation of 
fluid due to compaction causes the blastocyst to expand, forming an expanded blastocyst.  
Eventually a crack develops in the zona pellucida, and the blastocyst is released, forming 
a hatching blastocyst.  The steps by which the embryo forms all occur inside the zona 
pellucida, but the embryo continuously moves down the reproductive tract while 
developing inside (reviewed by Bazer et al., 1993). 
 The portion of the reproductive tract in which the embryo travels to the uterus is 
called the oviduct.  The oviduct consists of four distinct regions: infundibulum, ampulla, 
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ampullary-isthmic junction, and isthmus (reviewed by Ellington, 1991).  An oocyte is 
released by the ovulatory follicle into the infundibulum and transported to the ampulla.   
The ampulla is the area in which the oocyte is matured and prepared for sperm binding.  
Sperm are stored in the isthmus where they undergo capacitation and are prepared to 
fertilize the oocyte.  The sperm and oocyte meet at the ampullary-isthmic junction and 
are bound together.  A fertilized embryo will remain in the ampullary-isthmic junction for 
2.5-3 days.  Early embryos are unable to cleave and develop in the uterus; therefore, they 
must remain in the oviduct until approximately 72 hours post ovulation.    Once the 
embryo has reached the 16-cell stage, it travels into the uterus, where it remains for the 
duration of gestation (reviewed by Ellington, 1991).  The uterus consists of the uterine 
body and two horn-like structures on either side.  The horns each have an ovary at the tip, 
which will provide adequate hormones for maintaining pregnancy (reviewed by Bazer et 
al., 1993).   
 Hatching of the blastocyst occurs around day 9-11 of development.  The shedding 
of the zona pellucida is coincided with an accelerated growth of the blastocyst.  This 
rapid growth involves the enclosure of the blastocoele (inner cell mass) to form a 
bilaminar blastocyst.  The bilaminar blastocyst elongates to allow for attachment in the 
uterus later.  The extraembryonic endoderm cells involved in the closure develop the 
equivalent to the yolk sac.  This membrane will be involved in supplying nutrients to the 
early embryo.  Day 13 in the bovine species exhibits a logarithmic elongation of the 
blastocyst.  The corpus luteum (CL) that is responsible for pregnancy maintenance is 
located on the ovary ipsilateral to the uterine horn containing the embryo.  Generally, the 
elongated blastocyst will develop in the horn that has an ovary with a CL.  The embryo 
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will develop in the uterine horn until later elongation into the uterine body (reviewed by 
Bazer et al., 1993). 
2.2.2  Maternal recognition of pregnancy 
 Once the embryo is elongated and residing in the uterine horn, other changes must 
take place.  Certain processes must take place in order for the mother’s body to recognize 
that she is pregnant.  This process is known as maternal recognition of pregnancy.  The 
conceptus must release certain proteins in order for pregnancy recognition to take place.  
Bovine interferon-tau (IFN-τ) is the protein responsible for the maintenance of pregnancy 
(Bowen and Burghardt, 2000).  Production of PGF2α begins towards the end of a natural 
estrous cycle by the endometrium.  This release of PGF2α stimulates the release of OT by 
luteal cells, which enhances the release of PGF2α by the endometrium (Fuchs, 1987).  
Endometrial PGF2α excretion and continued OT release by the corpus luteum (CL) ensure 
a pulsatile release of PGF2α.  This pulsatile PGF2α lyses the CL; therefore, restarting the 
estrous cycle or causing embryonic mortality (Bowen and Burghardt, 2000).  Interferon-
tau must be released by the conceptus in order to prevent OT from causing luteal death 
(Bowen and Burghardt, 2000).       
 Bovine conceptus secretory hormones will enter the uterus about day 15 and 
inhibit uterine production of PGF2α.  The endometrium of pregnant cows does not 
respond to estradiol- and OT-induced uterine production of PGF2α, and has very low 
estrogen and oxytocin receptors on days 14-21, as opposed to cycling nonpregnant cows 
(reviewed by Bazer et al., 1993).  Prostaglandin F2α is the luteolytic agent in cattle, and is 
primarily secreted from the surface of the epithelium of the uterus.  The epithelium of the 
uterus is a glandular surface responsible for the release of regulatory proteins.  Oxytocin 
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is responsible for the pulsatile release of PGF2α, resulting in the lysing of the CL.  
Oxytocin stimulates the release of PGF2α from the endometrium, and uterine oxytocin 
receptors (OTR) to determine the sensitivity of the endometrium to OT stimulation.   In 
order for pregnancy to be maintained, the pulsatile action of the PGF2α must be 
eliminated.  Interferon-tau is produced by the trophoblast of the conceptus (Thatcher et 
al., 1997).  The secretion of this protein decreases the OTRs and therefore decreases the 
sensitivity of the endometrium to OT stimulation (Okuda et al., 2002).  The exact 
mechanism of how IFN-τ operates is not completely understood.  One mechanism 
theorized is that IFN-τ operates by reducing estradiol receptor number, therefore reducing 
estrogen-induced increase in OTR numbers.  Studies have indicated that IFN-τ also 
decreases the amount of cyclooxygenase-2 (COX-2), which is a precursor to the 
production of PGF2α.  This mechanism of decreasing COX-2 is believed to be 
independent of changes in OTR (Xiao et al., 1999).   
 Although IFN-τ reduces OTRs in the endometrium, this is probably not the sole 
effect the embryo has on PGF2α suppression.  Linoleic acid has been identified as 
inhibiting PGF2α synthesis in cows (Thatcher et al., 1994).  This inhibitor is released by 
the endometrium of pregnant cows.  Linolenic acid competes with arachidonic acid for 
the active site on the cyclooxygenase enzyme.  The cyclooxygenase enzyme is the key 
rate-limiting enzyme responsible for the conversion of arachidonic acid to precursors of 
PGF2α production (Xiao et al., 1999).  Interferon-tau can suppress the detrimental effects 
of PGF2α by acting on the oxytocin receptor gene.  The oxytocin receptor gene expression 
is induced by estrogen.  Studies suggest that IFN-τ affects oxytocin receptors through 
inhibitory actions on the estrogen receptors.  Type 1 interferons, such as IFN-τ, activate 
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protein kinase C (Thatcher et al., 1997).  Protein kinase C reduces concentrations of 
estrogen receptors by increasing the turnover of estrogen receptor mRNA.  Bazer et al. 
(1997) suggests that binding of type 1 interferon to its receptor activates the latent 
kinases, JAK1, and tyk2, which phosphorylate tyrosine residues of signal transducers and 
activators of transcription 1 (STAT1), STAT1A, and STAT2.  The activation of kinases 
JAK1 and tyk2 leads to a cascade of mechanisms that activate the negative transcription 
factor IRF-2.  Bazer’s studies suggest IFN-τ suppresses the estrogen receptor directly by 
binding to an IFN-τ responsive element in the estrogen receptor gene.  The exact 
mechanism of how IFN-τ down regulates the negative effects of OT and its receptors is 
not fully understood (Demmers et al., 2001).   
 The uterus must undergo critical changes in order for the embryo to survive.  The 
exact changes that are necessary are not fully understood.  The presence of progesterone, 
produced by the CL, stimulates the glandular epithelium of the uterus.  This epithelium is 
responsible for the secretion of proteins that become essential for conceptus development.  
Exact proteins secreted at the time of conceptus entrance into the uterus have not been 
identified in the bovine.  Human, pigs, and rats have been studied extensively, but the 
regulatory proteins are mainly species specific.  It is known that the growth factor, 
insulin-like growth factor II (IGF-II), produced by the uterine tissue and the embryo are 
essential for embryonic survival (reviewed by Bazer et al., 1993).  Though not much is 
known about the precise secretions needed for conceptus survival in the bovine uterus, 
certain known proteins are essential. 
 Changes in protein concentrations and physiological changes from the embryo 
and the uterus are needed for embryonic attachment.  The bovine trophoblast will first 
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develop finger-like villi (papillae) that will project into the lumen of the uterine glands.  
The papillae will provide a temporary attachment.  A loss of trophoblastic microvilli 
allows for close contact with the uterine epithelial microvilli.  The uterine epithelium 
presses into the trophoblastic surface, interlocking with the cytoplasmic projections on 
the trophoblastic surface.  This close surface contact between the epithelium of the uterus 
and the trophoblast of the conceptus allows a redevelopment of trophoblastic microvilli, 
and a more complex attachment (reviewed by Bazer et al., 1993). 
2.3  Causes of Embryonic Mortality 
 Reproductive wastage is a major cause of production loss in the beef and dairy 
industry.  Fertilization failure and embryonic mortality are suggested to be the main 
causes of reproductive wastage (reviewed by Ayalon, 1978).  Several factors are known 
to contribute to early embryonic mortality.  Nutrition, genetic make-up, heat stress, and 
management techniques are the main factors that have been examined through research.  
Early embryonic mortality is referred to as the losses experienced between fertilization 
and day 42 of gestation (Dunne et al., 2000).  Nutrition is thought to be a major factor 
contributing to reproductive failure in dairy animals. 
 Poor nutrition has always been directly associated with poor reproductive 
performance in dairy cows (Butler, 2000).  All dairy animals will experience a negative 
energy balance following parturition (O’Callaghan and Boland, 1999).  A negative 
energy balance occurs when the animal is unable to consume enough nutrients to account 
for the milk produced.  In order to meet the nutrient demands of high milk production 
following parturition, the animal will mobilize energy from its body reserves.  This 
process causes a loss of weight for the individual early in lactation.  The association 
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between negative energy balance and weight loss leads to a reduction in body condition 
score.  Body condition score (BCS) is a tool utilized by producers to evaluate the amount 
of reserves possessed by an animal.  The dairy industry uses a scale of 1-5.  A one score 
indicates a severe loss of reserve fat, usually associated with starvation.  A two score is 
more commonly seen in the early lactation animals.  A score of five is excessive fat 
reserves over the entire body; usually no bones are distinctly visible.  A negative energy 
balance has been shown to have a direct association with BCS (Snijders et al., 2001).  
Cows that experience weight loss early postpartum will exhibit a low BCS, and 
experience a negative energy balance comparable to the BCS (Snijders et al., 2001).  A 
low BCS has been shown to have a direct association with poor reproductive 
performance of dairy animals (Snijders et al., 2001). 
 Nutritional factors such as BCS and overall intake have been shown to have an 
effect on reproductive performance.  Severe body condition losses have been associated 
with a lower conception rate at first service (Butler and Smith, 1989).  This information 
indicates a link between the amount of body reserves and the chance of establishing 
pregnancy.  High nutritional intake has also shown negative effects on the developmental 
capacity of embryos (O’Callaghan et al., 2000).  Animals grouped in high and low intake 
groups were compared for reproductive performance.  The study indicated that animals 
experiencing high intake had lower conception rates on the first service (O’Callaghan et 
al., 2000).  High intake is needed for animals to compensate for high milk production, 
and the loss of body reserves in early lactation.  The mechanism of how high intake 
affects reproduction has been studied, but is not fully understood.   
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 The relationship between high intake and poor reproduction may be more 
associated with the oocyte than the embryo.  Studies revealed that high dietary intake and 
high metabolic load are detrimental to oocyte development and the establishment of 
pregnancy (O’Callaghan et al., 2000).  Supplementation of dietary fats through ration 
balancing has shown to slightly improve the developmental competence of the oocyte.  
Dietary fat supplementation is known to increase the size of preovulatory follicles (Lucy 
et al., 1993), increase the number of follicles (Wehrman et al., 1991), and increase the 
growth rate of dominant follicles (Oldick et al., 1997).  Studies have also shown that 
dietary fat supplementation increases the longevity of the corpus luteum (Williams, 1989) 
and increase production of progesterone (Hightshoe et al., 1991).   
 The increase of dietary fat in an animal’s ration provides a direct increase in 
conception rate (Staples et al., 1998).  The use of dietary fat to increase reproductive 
performance is not without negative attributes.  Increasing fat content of the diet can 
cause a dramatic weight gain, and result in metabolic problems later in lactation.  The 
reproductive parameters are increased, but only minimally enough to see significant 
differences statically.  The slight differences seen reproductively usually do not outweigh 
the metabolic problems experienced in later lactation.  The method of increasing dietary 
fat is used, but used very carefully.  The need for dietary changes to increase reproductive 
performance is mainly due to high milk production in early lactation.  The genetic make-
up of an animal is a contributing factor to high milk production. 
 High milk production is a genetic aspect that is examined by every dairy breeder 
in the industry.  Increased production costs have forced producers to obtain as much milk 
from each animal as possible.  Ideally this allows a more efficient operation and a lower 
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cost overall.  High milk yield has long been associated with poor reproductive 
performance.  Milk yield genetics are determined by examining the performance of the 
animal’s mother, and her father’s daughters.  Performance evaluation calculates into a 
number known as genetic merit.  Genetic merit predicts the productive performance of an 
animal based on her mother and siblings’ milk performance.  Studies have examined the 
effects of milk genetic merit on reproductive performance (Snijders et al., 1999; 
O'Callaghan et al., 2000; Snijders et al., 2001). 
 Reproductive performance comparisons of high and medium genetic merit 
animals have shown that high genetic merit animals have poorer reproductive 
performance (Snijders et al., 1999; Snijders et al., 2001).  High genetic merit (HGM) 
cows are animals that are bred to produce the maximum amount of milk.  Medium 
genetic merit (MGM) cows are bred to produce an average amount of milk compared 
over the entire breed.   Studies examining nutritional values of HGM and MGM cows 
were coupled with examining reproductive parameters (O'Callaghan et al., 2000).  
Several differences have been seen between HGM and MGM cows that indicate genetics 
play a major role in reproductive performance by influencing milk production and body 
condition (Snijders et al., 1999; Snijders et al., 2001).  Snijders et al. (1999) collected 
oocytes form high and medium genetic merit cows.  The number of oocytes collected did 
not differ between the two groups, but percent cleavage rate and number of blastocysts 
formed were significantly lower for high genetic merit cows (Snijders et al., 1999).  High 
genetic merit cows also had a lower body condition score at the time of calving (Snijders 
et al., 1999).  This data indicates that BCS may have an impact on oocyte quality.  In a 
later study Snijders and coworkers (2001) looked closer at the relationship of BCS and 
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reproductive performance.  HGM cows exhibited a lower body condition score during 
early lactation than MGM cows (Snijders et al., 2001).  A lower body condition score 
indicates a greater loss of body fat and decreased nutrients for oocyte development.  
Glucose and IGF-1 binding proteins were significantly lower for HGM cows at 2-10 
weeks postpartum (Snijders et al., 2001).  Glucose is needed for proper ovary function, 
and a lack of excessive glucose will result in poor ovulatory function (Snijders et al., 
2001).  HGM cows also exhibited a higher dietary intake than MGM cows (Snijders et 
al., 2001).  Studies performed by O’Callaghan and coworkers (2000) indicated that 
animals with a higher intake experienced a lower reproductive performance.  
 The comparison of HGM and MGM cow’s nutrition and reproductive 
performance indicated that genetic merit is a major contributing factor in reproductive 
failure.  Snijders et al. (2001) indicated that the glucose and IGF-1 were lower for HGM 
cows at 2-10 weeks postpartum.  HGM and MGM cows were bred during this same study 
and compared.  The plasma concentrations of glucose did not differ between HGM and 
MGM cows that established pregnancy on the first service (Snijders et al., 2001).  This 
information indicates that genetic merit is a greater negative factor than nutrition for 
reproductive problems (Snijders et al., 2001).  Nutrition would have been a greater 
problem, according to this study, if the plasma concentrations of glucose had been lower.  
Snijders and coworkers’ (2001) study also indicated that HGM cows had a lower 
conception rate on first and second services when compared to MGM cows.  There were 
also more HGM cows not pregnant at the end of the breeding season than MGM cows 
(Snijders et al., 2001).   Snijders and coworkers (2001) found no differences in the 
number of services per conception for HGM cows, but more services were needed for 
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HGM cows as a group.  These studies performed by Snijders et al. (1999, 2001) indicate 
that genetic merit plays a greater role in reproductive failure than once thought.     
 Heat stress is an environmental factor that is known to negatively influence 
reproductive performance (reviewed by De Rensis and Scaramuzzi, 2003).  De Rensis 
and Scaramuzzi (2003) conducted a review of the research that indicates heat stress can 
have a negative effect on the oocyte, ovary, and early embryonic development.  All of 
these negative factors lead to a decrease in reproductive performance, pregnancy rates, 
and an increase in days open.  Decreases in pregnancy rates due to heat stress have 
always plagued the animal industry and cost producers money.  
 Early studies in reproductive performance indicated that heat stress was causing a 
decrease in pregnancy of dairy cows.  Stott and Williams (1962) found that pregnancy 
rates were decreased by the summer heat of Arizona.  A pregnancy rate of 61.6% was 
reported in May, and the percentage fell throughout June and July.  The lowest 
conception rate (17.1%) occurred in August.  September recorded a 58.2% conception 
rate, which indicates that the heat had a dramatic effect on pregnancy rates.  However, 
heat was not the sole factor on the decreased conception rate during August.  Humidity 
also seems to affect pregnancy, as the percentage of humidity was greatest during the 
month of August. 
 Investigators hypothesized that another reason conception rates were low during 
the summer months was lack of estrous behavior.  Cows reportedly experienced long 
estrual intervals.  Long estrual intervals were identified as cows that were found not 
pregnant at the 35 day pregnancy check, but did not exhibit estrus before 35 days post 
insemination.  The long estrual intervals indicate that the heat affects the estrous cycle in 
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some manner (Stott and Williams, 1962).  The mechanism by which heat stress affects 
the estrous cycle of the cow is not fully understood by investigators in this field. 
 Heat stress is known to negatively affect the ovary and embryo.  Intensive study 
of the ovary during times of heat stress has provided some insight of the mechanism.  
Howell et al. (1994) examined the growth and function of the corpus luteum during 
spring and summer.  Summer months resulted in heat stressed dairy cows due to high 
ambient temperatures and relative humidity.  Spring months allowed animals to remain at 
a thermoneutral temperature.  Howell and coworkers reported that season did not affect 
the size of the corpus luteum, or the length of the luteal phase (Howell et al., 1994).  It 
was also reported that the peak progesterone concentration was significantly lower for the 
animals experiencing heat stress during the summer (Howell et al., 1994).  The authors 
concluded that hyperthermia may alter the functional characteristics of the corpus luteum 
cells (Howell et al., 1994). 
 Wilson et al. (1998) found that ovaries under the influence of heat stress had 
fewer follicles.  Wilson’s finding indicates that there is a disturbance in the follicular 
growth and function process.  Small ovulatory follicles and large subordinate follicles 
were found on ovaries of heat stressed animals.  Wilson et al. (1998) also found that the 
cows undergoing heat stress had lower concentrations of estradiol in blood serum.  The 
low levels of estradiol may contribute to the small ovulatory follicle size.  Estradiol also 
plays an important role in the luteolysis process in the cow.  Estradiol is released from the 
preovulatory follicle and increases blood concentrations.  Increased concentrations of 
estradiol will up-regulate the synthesis of the endometrial oxytocin receptor and activate 
enzymes associated with PGF2α production.  Oxytocin and estradiol bind to their 
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respective uterine receptors to initiate the pulsatile release of PGF2α.  The pulsatile 
release of PGF2α leads to the lysing of the corpus luteum and another estrous cycle.  The 
lack of estradiol delays the luteolysis process and allows the corpus luteum to remain 
intact (Wilson et al., 1998).   
 The failure of luteolysis is most likely why Stott and Williams (1962) observed a 
longer estrual interval during hot summer months.  Wilson et al. (1998) concluded that 
heat stress inhibited follicular growth during the preovulatory period.  Inhibition, as seen 
by a decrease in estradiol level, may cause small dominant follicles and excessive 
follicular waves each estrous cycle.  The conclusions were interpreted as an abnormal 
ovarian function due to heat stress (Wilson et al., 1998).  The effects of heat stress on 
ovarian function have been linked to a negative effect on embryonic development. 
 Poor follicular function leads to an incompetent oocyte.  Al-Katanani et al. (2002) 
collected oocytes from warm and cool season ovaries.  These oocytes were cultured and 
fertilized in vitro.  Oocytes and cleaved embryos from warm season collections had lower 
blastocyst development than cool season collections (Al-Katanani et al., 2002).  There 
was no reduction of cleavage rate of oocytes from warm season oocytes.  This suggests 
that heat stress does not affect oocyte maturation, sperm binding, and fertility.  Zygotes 
from warm season oocytes had a reduced competence to develop to blastocyst.  These 
findings suggest that the effects of heat stressed oocytes greatly affect early embryonic 
development (Al-Katanani et al., 2002).  Edwards and Hansen (1997) reported a reduced 
2 and 4 cell embryo development to blastocyst due to heat stress.  The development of 
compacted morulae was not affected by heat stress.  It was concluded that heat stress has 
the greatest effect on early embryonic development.  The embryo seems to develop a 
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resistance to heat stress following day 3 of development, and becomes less susceptible as 
it develops (Edwards and Hansen, 1997).  The fact that heat stress has a negative effect 
on early embryonic development leads to questions of how to prevent these effects. 
 Early studies indicated that embryonic loss due to heat stress occurred before day 
35 of gestation (Stott and Williams, 1962).  It was believed that cooling animals under 
heat stress prior to insemination would help establish pregnancy.  Al-Katanani et al. 
(2002) cooled animals to a temperature of 39.2 ± .1 °C for 42 days using fans and foggers 
before predicted ovulation.  Reports stated that the oocyte quality had not improved 
following this cooling (Al-Katanani et al., 2002).  Conclusions stated that cooling was not 
effective for several possible reasons: 1) the degree of cooling was not sufficient to 
prevent adverse effects of heat stress; 2) heat stress damaged the oocyte earlier in 
development than cooling was initiated, or 3) seasonal effects represent factors other than 
heat stress (Al-Katanani et al., 2002).  Conclusions from various studies indicate that heat 
stress affects the oocyte early in development.  It has been reported that primary follicles 
begin growth about 84 to 85 days before ovulation (Picton et al., 1998; McNatty et al., 
1999).  Adverse effects of heat stress on the oocyte potentially begin during the first steps 
of antral follicle development.  These general conclusions correspond with poor fertility 
in early cool seasons.  This may be due to oocytes experiencing heat stress during 
summer heat and being released as damaged oocytes in early cool seasons.   
 Studies are currently being conducted to further understand the effects of heat 
stress on early oocyte development.  Heat stress is known to decrease reproductive 
performance of lactating dairy cows.  The mechanism by which heat stress affects the 
oocyte, ovary, and early embryo is not fully understood.  Heat stress is one of several 
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factors that cause early embryonic mortality.  Nutrition, genetic merit, milk production, 
and heat stress all can have negative effects on reproductive performance, and all must be 
monitored in order to gain better reproductive performance. 
2.4  PGF2α Association With Early Embryonic Loss  
 Prostaglandins are biochemical compounds derived from arachidonic acid, a 
polysaturated fatty acid.  Prostaglandins are involved in several physiological processes 
such as inflammation, production of pain and fever, control of blood vessel tone and 
arterial blood pressure, luteolysis, and blood clotting (Nett, 1976; Seibert, 1994; Blatteis 
and Sehic, 1997).  The possible effects of prostaglandin on the early embryo are the focus 
of the following review. 
 Studies using “short cycle” cows indicate that a high level of PGF2α in the uterus 
may also cause early embryonic loss.  Short cycle animals are those that experience an 
estrous cycle less than or equal to 14 days (Schrick et al., 1993).  A normal cycling 
animal will have an estrous cycle of approximately 21 days.  Short cycle animals 
experience a premature release of PGF2α by a postpartum uterus after first exposure to 
progesterone (Cooper et al., 1991).  This premature release of PGF2α causes an early 
lysing of the corpus luteum.  A short cycle is often associated with the first estrus 
following parturition (Ramirez-Godinez et al., 1982).  Conception rates of 28% were 
reported on cows experiencing a short cycle (Butcher et al., 1992).  A 56% conception 
rate was reported on cows with a normal estrous cycle (Butcher et al., 1992).  These 
significantly different conception rates indicate that short cycle cows have an improper 
uterine environment for the oocyte or embryo, on or before day 7 of embryonic 
development (Butcher et al., 1992).   
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 Schrick et al. (1993) studied the quality of embryos from short cycle cows and 
normal cycling cows.  Schrick reported that the quality of embryos at day 6 of 
development did not differ in short cycle cows when compared to normal cycling cows.  
Pregnancy rates did not differ between short and normal cycling embryos when placed in 
a normal cycling uterine environment.  This information indicates that the lower 
conception rates seen in short cycling cows are taking place around day 7 or shortly after.  
Concentrations of PGF2α from uterine flushings were also recorded by Schrick.  Schrick 
reported that PGF2α concentrations were much higher in short cycling cows when 
compared to normal cycling cows.  High uterine concentrations of PGF2α indicate that the 
uterine environment in short cycle cows may be too poor for embryonic development.  
The findings by Schrick et al. (1993) indicate that the embryo is not affected prior to day 
6 of embryonic development in a high PGF2α concentration environment.   
 The decreased pregnancy rates in short cycling and normal cycling cows have 
been suggested to be the result of a regressing corpus luteum.  A regressing corpus 
luteum will produce and direct oxytocin towards the uterus for continued PGF2α 
production.  In vitro treatment of 8-cell rat embryos with PGF2α prevented development 
to the morula stage (Breuel et al., 1993).  The treatment of rabbit embryos with PGF2α 
prevented the formation of expanded or hatched blastocysts (Maurer and Beier, 1976).  
These studies suggest that embryonic development may be compromised by a direct 
action of PGF2α or an embryo toxic factor from the regressing corpus luteum.  Seals et al. 
(1998) studied in vivo embryonic development in progestogen supplemented cattle with a 
removed corpus luteum.  Animals involved in the study were bred and pregnancy 
checked at 30 days post artificial insemination (AI).  A control group was simply bred AI 
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and pregnancy checked.  Another group was administered PGF2α following breeding.  
The final group was administered PGF2α following breeding and underwent a lutectomy.  
Lutectomy is a procedure in which the corpus luteum is ruptured, or removed, in vivo by 
applying digital pressure.  Animals that underwent a lutectomy and PGF2α administration 
had increased pregnancy rates compared to those that were only administered PGF2α.  
Seal’s study suggested that a regressing corpus luteum may be needed to elevate 
concentrations of PGF2α high enough to lower embryonic survival rates. 
 Hockett et al. (2004) studied the effects of PGF2α administration on embryonic 
development in cattle.  Animals were assigned a control treatment of saline or 
administered PGF2α.  Hockett reported elevated concentrations of 13-14-dihydro-15-keto-
prostaglandin F2α (PGFM), the metabolized form of PGF2α, in the blood of PGF2α treated 
animals compared to animals that received saline.  A reduction in the quality score of the 
day 8-recovered embryos was observed in animals treated with PGF2α.  The development 
of the embryos between the two treatment groups was also studied.  Hockett et al. 
reported that many of the PGF2α-treated embryos did not develop beyond the morula 
stage, while all of the saline treated embryos had developed to maturity corresponding to 
the day of development.  Hockett concluded that embryos under the influence of PGF2α 
during days 5-8 of development suffer detrimental effects with respect to quality and 
development (Hockett et al., 2004). 
 Scenna et al. (2004a) studied the effects of PGF2α on pre-compacted in vitro-
derived embryos and compacted in vivo-derived embryos.  The study found that addition 
of PGF2α to culture medium of pre-compacted embryos had a direct negative effect on the 
embryo’s ability to develop to the blastocyst stage.  The addition of PGF2α to culture 
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medium of compacted in vivo-derived embryos did not affect the embryo’s ability to 
develop to blastocyst stage, but did significantly reduce hatching rates.  These results 
indicate that a negative effect of PGF2α may be occurring as early as or before day 5 of 
development.  The authors concluded that PGF2α may be disrupting tight junctions to 
result in decreased blastocyst development and hatching rates (Scenna et al., 2004a).  
2.5  Effects of PGF2α Inhibitors  
 Nonsteroidal anti-inflammatory drugs (NSAIDs) are drugs that inhibit production 
of prostaglandins associated with an inflammatory response (Vane, 1971).  Inflammatory 
responses are those associated with pain, fever, swelling, redness of tissue, and other 
injury related experiences (Vane and Botting, 1998).  The act of manipulating the 
reproductive tract during rectal palpation, an act involved in artificial insemination and 
embryo transfer, can cause an inflammatory response and the release of PGF2α (Wann 
and Randel, 1990; Velez et al., 1991).  Prostaglandin F2α exposure to an early embryo can 
compromise embryonic survival (Schrick et al., 1993; Breuel et al., 1993; Seals et al., 
1998; Lemaster et al., 1999; Hockett et al., 2004; Scenna et al., 2004a).  Prostaglandins 
released by an inflammatory response during artificial insemination and embryo transfer 
may be inhibited by NSAIDs. 
 Therapeutic activities of NSAIDs occur through inhibition of cyclooxygenase 
(COX).  The enzyme COX is involved in the production cascade required for the 
production of prostaglandins.  Research has indicated that there are at least two COX 
enzymes, COX-1 and COX-2.  Prostaglandins that protect the stomach and kidneys from 
damage are produced by COX-1.  Prostaglandins that contribute to the pain and swelling 
of inflammation are produced by COX-2.  Selecting NSAIDs to inhibit COX-2 should 
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prevent an anti-inflammatory response without damaging the stomach or kidneys (Vane 
and Botting, 1998).   
 Several NSAIDs have been used in research in an attempt to inhibit COX-2, 
which should block prostaglandins.  Prostaglandins are derived from arachidonic acid, 
which is oxygenated by COX-2.  Ibuprofen lysinate, aspirin, and flunixin meglumine are 
all NSAIDs that have been used in research to attempt to inhibit the production of 
prostaglandins.  The administration of flunixin meglumine has been shown to result in 
lower levels of PGF2α in the blood when administered 4 times daily (Aiumlamai et al., 
1990).  The PGF2α concentrations were reduced so to prevent luteolysis of the corpus 
luteum and prolong the estrous cycle (Aiumlamai et al., 1990).  Treatment with flunixin 
meglumine did not alter the PGF2α production cascade permanently.  Animals that 
underwent flunixin meglumine treatment experienced a significant decrease of PGF2α 
metabolite for 32, 20, and 16 hours following the final treatment.  All animals resumed 
normal hormonal activity following the conclusion of the treatment end (Aiumlamai et 
al., 1990).  The intensive treatment of animals with flunixin meglumine indicates that this 
NSAID has the ability to inhibit the production of PGF2α and extend the life of the corpus 
luteum, which is essential for the maintenance of pregnancy.  The fact that flunixin 
meglumine has the ability to inhibit PGF2α production leads to the question of whether 
PGF2α is released during manipulation of the reproductive tract. 
 Velez et al. (1991) and co-workers performed a study in which PGFM 
concentrations were measured following uterine manipulation.  Peripheral concentrations 
of PGFM reflect the endogenous uterine production of PGF2α.  Animals received gentle 
uterine manipulation for 2 minutes at a time.  One group received manipulation weekly 
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from days 9-51 postpartum.  Another group received manipulation one time between 29-
35 days postpartum.  Blood collections were taken from each group and PGFM 
concentrations were measured.  Results indicated that PGFM concentrations elevated 
during the weekly manipulation, and elevated for the one time manipulation at day 30 
postpartum on average.  These results indicated that uterine manipulation does increase 
the uterine production of PGF2α (Velez et al., 1991).  Uterine manipulation for this study 
occurred over a two minute time period, which may be longer than most artificial 
insemination and embryo transfer manipulations. 
 Odensvik and coworkers (1993) performed a study in which the levels of PGF2α 
were measured following non-surgical embryo transfer in cattle.  Prostaglandin 
metabolite levels in the blood were measured to indicate PGF2α levels.  Blood was 
collected every 10 minutes, beginning 50 minutes before embryo transfer and continuing 
for about 5 hours following embryo transfer.  Each transfer was classified as easy, 
medium or difficult based on the amount of effort required to insert the catheter in the 
correct location of the uterine horn.  Standard embryo transfer procedure requires a 
rubber catheter to be inserted two-thirds of the way into the uterine horn.  Most embryos 
are at 7 days of development when transfer is performed; therefore, they must be placed 
where development is occurring for a 7 day embryo.  The investigators found no 
significant change in prostaglandin F2α metabolite level pattern during embryo transfer.  
Furthermore, concentrations of PGFM did not differ between the transfer difficulty 
groups.  The results of this study indicate that the manipulation of the reproductive tract 
during embryo transfer did not increase concentrations of PGFM (Odensvik et al., 1993).  
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 Studies have been performed in humans and cattle to determine whether NSAIDs 
may increase reproductive performance following embryo transfer.  Rubinstein and 
coworkers (1999) treated human patients with low-dose aspirin during in vitro 
fertilization procedures.  The study found that the number of follicles, number of oocytes 
retrieved, implantation rate, and pregnancy rates were significantly higher for patients 
receiving low-dose aspirin treatment.  These results indicate that the NSAID aspirin can 
increase reproductive performance and pregnancy rates by potentially inhibiting 
prostaglandin (Rubinstein et al., 1999).   
 Lemaster et al. (1999) performed a study indicating that the NSAID flunixin 
meglumine was effective in blocking the negative effects of PGF2α and therefore 
increasing pregnancy rates.  Animals were treated with oxytocin + flunixin meglumine 
(OT + FM), OT, or OT + lutectomy (LUT) following breeding.  Lemaster et al. reported 
that animals administered OT + FM resulted in pregnancy rates similar to that of the 
controls.  Pregnancy rates of OT and OT + LUT treated animals were significantly 
reduced compared to controls and OT + FM.  This information indicates that flunixin 
meglumine may inhibit the detrimental effects of PGF2α on early embryonic development 
(Lemaster et al., 1999). 
 Elli and coworkers (2001) performed study using ibuprofen lysinate, an NSAID, 
in bovine embryo transfer.  Embryos were transferred into heifers that were classified as 
being acceptable to receive an embryo.  Half of the animals received an injection of 
ibuprofen lysinate before embryo transfer; the other half received a placebo treatment.  
Pregnancy rates for animals receiving ibuprofen lysinate and controls were 82% and 56% 
respectively.  A significant improvement was reported for those animals that received 
ibuprofen lysinate (Elli et al., 2001). 
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 The use of flunixin meglumine has been studied in cattle in an attempt to improve 
reproductive performance during embryo transfer.  McNaughtan et al. (2001) conducted a 
study in which heifers were administered FM prior to embryo transfer.  Pregnancy rates 
were not statistically improved with administration of FM (McNaughtan et al., 2001).  
However the authors reported that a logistics analysis of the odds ratio indicated that 
heifers were 1.22 times more likely to become pregnant when administered FM prior to 
transfer (McNaughtan et al., 2001).  Scenna et al. (2004b) performed a study in which 
animals were administered flunixin meglumine or saline at the time of embryo transfer.  
The results of the study indicated that a significant improvement in pregnancy rates 
occurred for those animals administered flunixin meglumine.  Animals administered 
flunixin meglumine resulted in pregnancy rates of 65%, while animals administered 
saline resulted in 60%.  Flunixin meglumine also significantly increased pregnancy rates 
for quality score 2 embryos (64.5 vs 53.5%; respectively), and morula and blastocyst 
stage embryos (64.5 vs 58.9%: 66.5 vs 59.5%; respectively).  This administration was a 
single dose and resulted in improvement of pregnancy rates by potentially inhibiting the 
effects of PGF2α (Scenna et. al., 2004b).  These results contradict those of Aiumlamai et 
al. (1990) with respect to dosage.  Aiumlamai et al. (1990) reported that intensive dosing 
(4 doses per day) was required to have positive effects with flunixin meglumine.  
Flunixin meglumine is preferred in cattle because it has other therapeutic uses and is 
readily available to the animal producer. 
 Embryo transfer is a procedure that involves many of the uterine manipulations 
involved in artificial insemination.  Reports indicate that NSAIDs have a positive effect 
on pregnancy rates during embryo transfer in humans (Rubinstein et al., 1999) and in 
cattle (Elli et al., 2001; Scenna et al., 2004b).  The fact that flunixin meglumine has been 
 33
reported to have positive effects is promising for the animal producer.  Flunixin 
meglumine could be used during artificial insemination to increase pregnancy rates since 
uterine manipulations are similar.  The key to flunixin meglumine administration is 
discovering the best time to administer the NSAIDS to maximize the possible positive 
effect.  Embryos are transferred at 7 days of development, but the embryo does not exist 
when artificial insemination is performed.  Researchers involved in this field predict that 
days 4-6 following artificial insemination may be the best time to administer flunixin 
meglumine.  Studies have not been performed to test this hypothesis.   
2.6  Summary of the Literature 
 Early embryonic death is a problem that plagues dairy producers worldwide.  
High milk demands have forced producers to feed highly concentrated rations, breed for 
high milk yield, and concentrate more animals in a centralized location.  These factors 
have contributed to a decline in reproductive efficiency of dairy animals over the past 
decades.  Research has been conducted in attempts to improve reproductive performance 
without compromising milk yield.  Unfortunately, more studies are needed before 
acceptable reproductive levels are reached. 
 The presence of PGF2α has been shown to have a negative effect on early 
embryonic development.  Controlling PGF2α during early embryonic development may 
decrease early loss.  Flunixin meglumine has successfully been used to block PGF2α 
synthesis in cattle.  Flunixin meglumine has also been shown to increase pregnancy rates 
when administered immediately following embryo transfer.  The use of flunixin 
meglumine on day five following artificial insemination may improve pregnancy rates for 
the dairy industry.  
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 The objective of this study is to determine if administration of flunixin meglumine 
on day 5 following artificial insemination can increase reproductive efficiency in 
lactating dairy cattle. 
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3.  Materials and Methods 
 All experimental materials were provided by Schering-Plough Animal Health 
Corporation (SPAHC; Union, NJ) unless otherwise noted.  The experiment was 
conducted from September, 2002 through April, 2003 at the University of Tennessee 
Knoxville Experiment Station (KES) Dairy Unit.  Animal/and nutritional management 
were performed as regular facility practices at the KES Dairy Unit.  A total of 121 
Holstein and Jersey cows (Table 1) were randomly assigned to receive a treatment of 
flunixin meglumine or saline following estrous synchronization and artificial 
insemination.  Ultimately, 106 animals were used for final data analysis as discussed in 
the results section.  
 All animals involved in estrous synchronization and treatment assignment were at 
least 60 days in milk, ≥ 364 kg body weight (BW), and identified as being reproductively 
sound by the attending herd veterinarian.  Animals underwent estrous synchronization 
using a two-injection protocol of Estrumate (cloprostenol, 500 µg).  One injection of 
Estrumate (2 mL) was administered intramuscularly to initiate estrous synchronization.  
Animals were fitted with a radiotelemetric estrous detection system (HeatWatch Estrus 
Detection System, DDX, Inc., Denver, CO).  Standing estrus was defined as ≥ 3 mounts 
of ≥ 2 sec within a 4-hour period as detected by HeatWatch, or visual confirmation of an 
animal standing to be mounted by a herd mate.  Animals exhibiting standing estrus were 
artificially inseminated 12 ± 6 h following first detection of standing estrus utilizing one 
0.5 mL straw of semen.  Semen was used from various Holstein and Jersey bulls of 
proven fertility (semen obtained by University of Tennessee KES).  Animals not 
exhibiting standing estrus following the first injection of Estrumate 
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Table 1.  Description of animal numbers and production characteristics. 
 
 
 
aMP = Milk Production 
b305 ME = 305 Mature Equivalent 
cBW = Body weight 
dBCS = Body Condition Score (1, thin to 5, fat) 
eDIM = Days in Milk 
 
Variable Number Animals SAL FM 
 
Cows 
 
106 
 
51 
 
55 
1st Lactation 50 24 26 
2nd Lactation 30 15 15 
3+ Lactation 26 12 14 
Holstein 71 34 37 
Jersey 35 17 18 
rBST 71 34 37 
MP (kg/d)a  33.5 33.9 
305 ME (kg)b  10,959 10,636 
BW (kg)c  528 548 
BCSd  2.8 2.9 
DIM (d)e  131 149 
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 received a second injection 11 days following the initial injection.  Animals experiencing 
standing estrus following the second injection of Estrumate were inseminated as defined 
previously.  Animals not exhibiting standing estrus following the two-injection protocol 
were recycled into the estrous synchronization program for no more than two additional 
attempts.  
 Treatment with flunixin meglumine or saline was randomly assigned between 
primiparous and multiparous cows.  Treatment was administered intravenously in the 
vena cava (FM, 2.2 mg/kg BW; SAL, 1 mL/23 kg of BW) 5 days ± 12 h following 
artificial insemination.  Body weight was determined using certified scales (Tru-Test 
SR2000, Tru-Test Limited, Auckland, New Zealand) immediately prior to treatment 
administration.  Milk from FM treated cows was discarded for 36 hours (3 milkings) 
following treatment as directed by the FDA.   
 Pregnancy was determined at 28-35 days post artificial insemination by the 
presence of an embryo with a heartbeat by transrectal ultrasonography (SIUI, CTS-200V; 
Shantou, Guangdong, China) equipped with a 5.0 MHz linear transducer. The ultrasound 
technician was blinded with respect to treatment.  Any animal not pregnant following 
pregnancy determination was not re-enrolled in the experiment. 
 Additional variables of interest (Table 1) included breed, lactation number (LN), 
days in milk (DIM), actual milk production (MP), 305 mature equivalent (ME), BW,  
body condition score (BCS), and if the animal was under the influence of recombinant 
bovine somatotropin (rBST; POSILAC®, Monsanto Company, St. Louis, MO).  Days in 
milk was determined on the day of treatment with FM or SAL.  Data for 305 ME were 
calculated by PC-DART (Dairy Records Processing Center, Raleigh, NC).  Milk 
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production was calculated by averaging the daily milk weights (obtained by HerdMaster® 
Management System, Alfa-Laval Agri Inc., Kansas City, MO) of 3 days prior, the day of, 
and 3 days following treatment.  Lactation number was divided into three groups of 1, 2, 
and 3+.  Days in milk were grouped as high (> 150 d), medium (75-150 d), and low (< 75 
d).  Daily milk production was grouped as high (> 36 kg), medium (36-27 kg), and low 
(< 27 kg).  Groups of 305 ME were established as high (> 11,818kg), medium (10,000-
11,818 kg), and low (< 10,000 kg).  Body weight was grouped as high (> 591 kg), 
medium (454-591 kg), and low (< 454 kg).  Recombinant BST administration was 
determined as whether or not a cow was under the influence of rBST at the time of 
artificial insemination.  Body condition score was assigned to an individual at the time of 
pregnancy determination by one of two qualified technicians.   
3.1  Statistical Analysis 
 Differences in pregnancy rates were analyzed by using Mixed Models of SAS 
(SAS, 2000) in a completely randomized design.  All cows were equally assigned to 
treatment with regards to breed, lactation number, rBST, BCS, BW, MP, DIM, and 305 
ME and all interactions as fixed effects were used to compare differences among 
treatments.  Animal (treatment x lactation x breed) was included as a random effect.  
Differences in individual least squares means were evaluated using LSD.  Also, 
pregnancy rates were validated using Fisher’s Exact Test (SAS, 2000).  This test requires 
the fewest assumptions when dealing with percentage data.  A value of P < 0.05 was 
considered statistically different. 
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4.  Results 
 A total of 24 estrous synchronization repetitions were performed during the 
course of the study.  The 24 replicates averaged 8.3 animals for a total of 199 animals 
entering the estrus synchronization protocol.  Some of the 199 animals synchronized 
were synchronized in more than one replicate due to no response during the previous 
synchronization attempt.  Seventy-nine animals (65.3%) responded with estrus following 
the first injection of Estrumate, while 42 animals (34.7%) responded following the 
second injection.  A total of 121 animals responded to synchronization and were 
artificially inseminated. 
 Of 121 cows utilized for the study, two animals were removed from the study 
prior to pregnancy confirmation due to ambulatory health problems.  Six animals were 
artificially inseminated outside of the 12 ± 6 h window following standing estrus.  Four 
animals were mistakenly artificially inseminated on spontaneous estrus prior to 
confirmation of pregnancy.  Two animals were treated outside of the 5 d ± 12 h window 
following artificial insemination.  One animal mistakenly received an injection of PGF2α 
by farm personnel prior to pregnancy confirmation.  All fifteen of these animals 
mentioned were not included in the data analysis since none of these procedures met the 
protocol of the study.  A total of 106 animals were ultimately utilized for data analysis 
(Table 1).  
 Administration of FM 5 days following artificial insemination did not improve 
pregnancy rates compared to controls (FM= 37.0, SAL = 31.4%; P > 0.10; Figure 1).  No 
significant differences were detected between FM and SAL treatment within rBST 
administration group or lactation group (Table 2).  Animals in the high, medium, and low 
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Figure 1.  Effect of treatment on pregnancy rates.  Treatment with flunixin (FM) or saline 
(SAL) did not alter pregnancy rates. (A P > 0.10) 
A
A 
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Table 2.  Effect of treatment with flunixin meglumine (FM) or saline (SAL) on 
pregnancy rates for cows administered rBST (rBST +) or not administered rBST (rBST -) 
and within lactational groups (1, 2, 3 +).  Treatment with FM or SAL did alter pregnancy 
rates regardless of rBST administration or lactational group (ABCDE P > 0.10). 
 
 
                         FM SAL 
rBST - 39.1A 28.0A 
rBST + 40.8B 54.2B 
LN 1 42.3C 45.8C 
LN 2 40.0D 40.0D 
LN 3 + 28.6E 8.3E 
 
 
milk production groups did not differ in pregnancy rates between the two treatments 
(Figure 2).  Cows in the high, medium, and low 305 ME groups did not differ in 
pregnancy rates between the two treatments (Figure 3).  Treatment with FM or SAL did 
not alter pregnancy rates within low and moderate BCS groups (Figure 4).  However, 
treatment with FM did increase pregnancy rates for moderate BCS cows compared to low 
BCS cows treated with FM (Figure 4).  Cows treated with FM or SAL within different 
DIM groups did not differ in pregnancy rates (Figure 5).   
Factors associated with high milk production were also investigated to determine 
if these factors had an effect on pregnancy rates regardless of treatment.  Cows in the 
high, medium, and low milk production and 305 ME groups did not differ in pregnancy 
rates (Figure 6).  Breed did not effect pregnancy rates to a significant level.  Holstein  
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Figure 2.  Effect of treatment with flunixin meglumine (FM) or saline (SAL) on
pregnancy rates between low, medium, and high milk production groups.  Neither
treatment with FM nor SAL affected pregnancy rates among the different milk 
production groups (A P > 0.10).   
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Figure 3.  Effect of treatment with flunixin meglumine (FM) or saline (SAL) on
pregnancy rates among different 305 mature equivalent (ME) groups.  Treatment
with FM or SAL did not result in any significant differences in pregnancy rates 
between the low, medium and high 305 ME groups (A P > 0.10). 
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Figure 4.  Effect of treatment with flunixin meglumine (FM) or saline (SAL) on 
pregnancy rates for cows in the low (1-2.5) and moderate (3-5) body condition score 
groups.  Cows within each body condition score group did not differ in pregnancy rates 
regardless of treatment.  Cows treated with FM in the moderate body condition score 
group did have higher pregnancy rates compared to cows in the low body condition score 
group treated with FM (* P < 0.05, A P > 0.10). 
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Figure 5.  Effect of treatment with flunixin meglumine (FM) or saline (SAL) on 
pregnancy rates among different days in milk (DIM) groups.  Treatment did not 
result in a significant difference in pregnancy rates for cows in the low, medium, 
and high DIM groups (A P > 0.10).   
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Figure 6.  Effect of milk production and 305 ME group on pregnancy rates.  Milk 
production (MP) and 305 mature equivalent (305 ME) did not have any 
significant effect on pregnancy rates (A P > .10).   
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cows had a pregnancy rate of 33.8%, while Jersey cows had a pregnancy rate of 42.9% (P 
> 0.10).  Administration of rBST did have an effect on pregnancy rates by lowering 
pregnancy rates for all cows and Jersey cows; however, no differences were detected 
within the Holstein breed (Figure 7).  Administration of rBST to all cows and Jersey 
cows < 100 DIM also lowered pregnancy rates, but no differences were detected within 
the Holsteins (Figure 8).  Lactation (LN) group tended to decrease (P = 0.09) pregnancy 
rates with increasing lactations, but rBST administration did not alter pregnancy rates 
within LN group (Table 3).  Jersey cows in LN 1 had higher pregnancy rates (72.7%), 
while Jersey cows in LN 2 and 3+ were lower (38.5 and 18.2%, respectively; P < 0.05).  
However, Holstein cows did not have a significant difference in pregnancy rates with 
respect to LN number (1=35.9, 2=41.2, and 3+ =20%; P > 0.10).   
Cows with a BCS of  ≤ 2.5 and ≥ 3 resulted in pregnancy rates of 31.5 and 37.5%, 
respectively (P > 0.10).  However, cows with a BCS of ≥ 3 tended to have lower 
pregnancy rates when administered rBST (33.4%) compared to those not administered 
rBST (60.4%; P = 0.07).   
 48
Figure 7.  Effect of rBST administration (rBST +) or no rBST administration (rBST -) 
on pregnancy rates.  Administration of rBST significantly decreased pregnancy rates in
all cows (A, a P < 0.05).  However, administration of rBST did not reduce pregnancy
rates in Holstein cows (B P > 0.10).  Jersey cows administered rBST did exhibit a
significant decrease in pregnancy rates (C, c P < 0.05). 
0
10
20
30
40
50
60
70
80
90
100
All Cows Holstein Jersey
Pe
rc
en
t P
re
gn
an
t
rBST + rBST -
A
a
B
B
C
c
 49
Figure 8.  Effects of rBST administration (rBST + or rBST -) on pregnancy rates 
for cows < 100 days in milk (DIM).  Administration of rBST significantly 
decreased pregnancy rates compared to cows not receiving rBST (A, a P < 0.05).  
However, only a breed by rBST administration interaction was noted in Jersey (C, 
c P < 0.05) but not Holstein cows (B P > 0.10). 
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Table 3.  Effect of lactation (LN) group and rBST administration (rBST +) or no rBST 
administration (rBST -) on pregnancy rates within lactation group.  Pregnancy rates 
tended to decrease between LN 1 and LN 3 + (Aa P = 0.08).  Administration of rBST did 
not alter pregnancy rates within lactation group (BCD P > 0.10).  
         
           1 2 3 + 
n 50 30 26 
 44.1A 40Aa 18.5a 
rBST + 42.3B 37.4C 13.6D 
rBST - 46.5B 50.0C 41.7D 
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5.  Discussion 
 The present experiment was conducted to examine the effects of flunixin 
meglumine administration on the establishment of pregnancy following artificial 
insemination.  Interest was also focused towards other factors (rBST, BCS, DIM, 305ME, 
lactation number, and breed) that may have negative effects on reproductive performance 
in lactating dairy cattle.  It was hypothesized that the stressor of high milk production, 
and factors associated with high milk production, would result in an increase of PGF2α 
levels 5 days following artificial insemination such that a positive effect of FM on 
pregnancy rates would be observed. 
No significant differences were detected between FM and SAL treatment for 
overall pregnancy rates and within rBST administration group, lactation group, milk 
production group, or 305 ME group.  A significant affect of treatment on pregnancy rates 
was detected with respect to BCS.  Animals with a BCS of ≥ 3 experienced increased 
pregnancy rates compared to a BCS of ≤ 2.5 when treated with FM.  However, all results 
should be interpreted with caution due to the limited number of animals available and 
utilized in this study.   
 It is established that FM can be utilized as an adequate inhibitor of PGF2α 
(Odensvik, 1995; Konigsson et al., 2003).  Positive effects of FM (a NSAID) on 
pregnancy rates seemed logical following the demonstrations of Elli et al. (2001) and 
Scenna et al. (2004b) that ibuprofen lysinate and FM, respectively, increased pregnancy 
rates following embryo transfer.  Aiumlamai et al. (1990) and Odensvik et al. (1998) also 
demonstrated that the use of FM could be used to prevent luteolysis and prolong the 
estrous cycle.  The most detrimental effects of PGF2α on embryonic development tend to 
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occur during morula, compacted morula, and blastocyst development (Seals et al., 1998; 
Hockett et al., 2004; Scenna et al., 2004a).  This stage of development corresponds to day 
5-7 of development; thus, treatment with FM on day 5 following artificial insemination 
seemed logical.  However, treatment on day 5 may have been too early considering 
successful uses of FM with embryo transfer (Scenna et al., 2004b) involved embryos at 
day 7 of development. 
Another factor that may have contributed to similar pregnancy rates between FM 
and SAL treatments is the absence of an adequate stressor.  It was hypothesized that high 
milk production and factors associated with high milk production would serve as an 
adequate stressor to increase uterine PGF2α levels.  According to the data analysis, milk 
production and these factors did not have an influence on pregnancy rates between the 
two treatment groups.  Previous studies involving embryo transfer and the use of FM 
involved the stressor of embryo transfer on animals that did not encounter intense human 
contact.  The intense daily contact involved with lactating dairy animals may have 
alleviated a stressor commonly involved with beef cattle and dairy heifers.  Further 
studies with FM in dairy cattle in this research area may need to take place during a time 
of additional stress, such as elevated ambient temperature.   
Route of administration of FM is another issue that may have resulted in few 
differences in pregnancy rates between treatment groups.  Three routes of administration 
of FM have been studied in the past: oral (granules) (Odensvik, 1995; Odensvik et al., 
1998; Konigsson et al., 2003), intramuscular (Konigsson et al., 2003; Scenna et al., 
2004b;) and intravenous (Odensvik et al., 1993; Odensvik, 1995; Aiumlamai et al., 1990; 
Konigsson et al., 2003).  Odensvik et al. (1995) and Konigsson et al. (2003) found no 
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differences in route of administration and the ability of FM to inhibit the synthesis of 
PGF2α.  Intensive oral administration of FM granules was found to significantly increase 
the length of the estrous cycle (Odensvik et al., 1998).  Intensive intravenous 
administration of FM was found to also delay normal luteolysis and prolong the estrous 
cycle (Aiumlamai et al., 1990).  However, we are unaware of any publications indicating 
successful increases in pregnancy rates utilizing an intravenous administration of FM.  
Successful increases in pregnancy rates were obtained by Elli et al. (2001) and Scenna et 
al. (2004b) utilizing an intramuscular administration of ibuprofen lysinate and FM, 
respectively. 
 First-lactation cows involved in this study experienced a higher pregnancy rate 
than cows in lactation 2 and 3+.  These results are contradictory to work concerning first-
lactation animals and negative energy balance.  First-lactation cows have a lower energy 
balance because they consume less and have higher energy requirements for growth and 
lactation (reviewed by Lucy, 2001).  Lucy et al. (1992) associated a lower energy balance 
in first-lactation cows with delayed intervals to first ovulation.  Negative energy balance, 
which may be more severe in first parity has been associated with poor reproductive 
performance (Butler and Smith, 1989; Butler, 2000; Snijders et al., 2001; Butler, 2003).  
Loeffler et al. (1999) identified first parity as a risk for conception failure at first service.  
Several studies indicate that reproductive performance should be better with multiparous 
cows.  Milk production is the only logical explanation as to why reproductive 
performance was better in first-lactation cows.  First lactation cows generally give less 
milk than multiparous cows; therefore, the stress of high milk production is not hindering 
reproduction.  Factors associated with high milk production and actual production has 
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been associated with lowered reproductive performance (Snijders et al., 1999; 
O’Callaghan et al., 2000; Lucy, 2001; Snijders et al., 2001; Lopez et al., 2004). 
The level of milk production of the cattle involved in this study did not result in 
significant differences in pregnancy rates for all cows.  This data disagrees with the work 
of several investigators, which indicate that milk production and genetic selecting for 
high milk production can decrease fertility in dairy cattle.  O’Callaghan et al. (2000) and 
Snijders et al. (2001) both indicated that selecting for high producing cows can decrease 
fertility.  The work of O’Callaghan et al. (2000) and Snijders et al. (2001) focused on the 
nutritional needs of high producing animals.  These investigators concluded that selecting 
for high producing cows forces a high dietary intake, which leads to a decrease in 
reproductive performance.  Lopez and coworkers (2004) indicated that high producing 
cows have a lowered intensity of estrus.  Pregnancy rates for animals in the low, medium, 
and high MP groups in this study were 41.4, 41.8, and 18.2%, (P = 0.10) respectively.  
Although not statistically different, the high MP group had lower pregnancy rates 
numerically.  Perhaps a greater number of cows would have resulted in a statistically 
significant decrease of pregnancy rates related to milk production.     
The stage of lactation for animals involved in this study significantly affected 
pregnancy rates.  A significant difference in pregnancy rates was detected between 
Holstein and Jersey cows less than 100 DIM.  These results are most likely the result of 
increased milk production by Holstein cows.  High milk production and selection for high 
milk production has been associated with poor reproductive performance (Snijders et al., 
1999; O’Callaghan et al., 2000; Snijders et al., 2001; Lopez et al., 2004).  Animals less 
than 100 DIM and administered rBST resulted in a significant difference in pregnancy 
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rates for all cows, and Jersey cows.  Cole at al. (1991) reported that treatment with rBST 
in early lactation resulted in a downward shift of energy balance that did not return to 
control level for 12 weeks.  This information may explain why cows less than 100 DIM 
and administered rBST had significantly lower pregnancy rates.  These cows in early 
lactation were most likely already experiencing a negative energy balance, and 
administration of rBST may have maintained or increased the severity of the negative 
energy balance.   
Recombinant BST did have a negative effect on reproductive performance for the 
cows involved in this study.  A decrease in pregnancy rates was greatest for cows less 
than 100 DIM.  Other reports have indicated that rBST has a negative effect on 
pregnancy in lactating dairy cattle (Cole et al., 1991; Cole et al., 1992; reviewed by 
Dohoo et al., 2003).  Dohoo and coworkers (2003) concluded in a review of published 
data that rBST use in non-pregnant cows increased the risk of a cow not becoming 
pregnant by 40%.  Cole and coworkers’ (1991) observations for reduced pregnancy rates 
of rBST-treated cows also were detected in early lactation cows.  In contrast, Santos et al. 
(2004) reported that rBST use tended to reduce embryonic mortality.  The mechanism in 
which rBST may or may not hinder reproductive performance is not fully understood, but 
several theoretical explanations have been published. 
The most consistent explanation for decreased reproductive performance due to 
rBST administration in the reviewed literature has been a decrease in expression of estrus 
(Cole et al., 1991; Morbeck et al., 1991; Waterman et al., 1993; Santos et al., 2004).  
Along with decreased estrus expression, it has been reported that rBST is related to 
increased days to first service, services/conception, and days open (Cole et al., 1991; 
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Morbeck et al., 1991).  The best possible explanation for reduced reproductive 
performance related to rBST found in a review of the literature is an alteration in 
follicular development (De La Sota et al., 1993; Lucy et al., 1993; Lucy et al., 1994; Lucy 
et al., 1995; Kirby et al., 1997a; Kirby et al., 1997b; Santos et al., 2004).  De La Sota 
(1993) reported that the second largest follicle involved in the second follicular wave was 
larger in cows treated with rBST.  De La Sota concluded that rBST might change the 
relationship between the dominant and subordinate follicles to which the dominant 
follicle loses some ability to suppress the subordinate follicle.  Lucy et al. (1994) and 
Kirby et al. (1997a) reported that rBST treatment resulted in reduced period of 
dominance for the first follicular wave and an earlier recruitment of the second wave 
follicle.  This earlier recruitment allows for an extended period of dominance for the 
second wave follicle.  Austin et al. (1999) reported that an extended period of dominance 
is associated with reduced oocyte viability and subsequent fertility.  Kirby et al. (1997b) 
reported that cows treated with rBST have reduced FSH; therefore, resulting in a faster 
turnover of the dominant follicle and a change in the timing of the follicular waves.  
Santos et al. (2004) concluded that all factors related to alteration follicular development 
might be the cause of poor reproductive performance associated with rBST.  If rBST is 
causing a change in the viability of the second follicular wave and beyond, then anything 
but a first follicular wave insemination may be in jeopardy.  Nevertheless, much research 
is still needed to fully understand the effect rBST on reproduction. 
Body condition score did not have a significant impact on the pregnancy rates of 
the cattle involved in this study.  Body condition score has been shown to have a direct 
association with energy balance (Snijders et al. 2001).  Butler and Smith (1989) reported 
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that severe body condition loss was associated with lower conception rate for first 
service.  Butler (2000) reported that poor fertility in high producing cattle was partially 
the result of a negative energy balance.  Studies have shown that BCS can be directly 
associated with reproductive performance.  Gillund et al. (2001) reported that cows with 
BCS loss of ≥ 1.25 units following calving were half as likely to conceive at first service 
as cows with more modest loss.  Stevenson et al. (1999) reported that conception rates 
increased by 10% for every unit increased in BCS.  A large study found that cows with a 
BCS of 3 at insemination are most likely to become pregnant (Loeffler et al., 1999).  The 
information indicating that negative energy balance and BCS at the time of insemination 
are related to reproductive performance agrees on some levels with the data presented in 
this study.  Overall there was no statistical difference detected in pregnancy rates with 
respect to BCS, but cows with a BCS of 3.5 were numerically higher at 62.5% compared 
to 44.44, 30.0, and 36.84% for BCS of 2, 2.5, and 3.  These results agree with the 
indication that cows must be in a sound state of energy balance and BCS in order to 
perform well reproductively.  However, these results disagree with Loeffler et al. (1999) 
that a BCS of 3 result in the highest pregnancy rates.   
Results of this study also indicated that rBST along with BCS had a tendency to 
affect pregnancy rates.  The fact that rBST had a tendency to lower pregnancy rates for 
cows with a BCS of 3 is puzzling considering no effect was detected for rBST 
administered cows at a BCS of 2.  The information from previous investigators indicates 
that rBST may decrease reproductive performance (Cole et al., 1991; Cole et al., 1992; 
reviewed by Dohoo et al., 2003).  A low body condition score of 2 along with 
administration of rBST should decrease reproductive performance.  However, the animals 
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with the ideal BCS of 3 were experiencing the greatest loss of reproductive function 
when administered rBST.  Perhaps an animal must be in a state of adequate body 
condition before a difference can be noticed.            
In conclusion administration of FM on day 5 following artificial insemination did 
not result in increased pregnancy rates.  This finding may be due to timing of 
administration, route of administration, absence of an adequate stressor, or the limited 
number of animals utilized.  More research is needed to address the timing and route of 
administration of FM following artificial insemination.  Also, no significant effect on 
pregnancy rates were detected with respect to breed, DIM, BCS, MP or 305ME.  
However, pregnancy rates had a tendency to decrease for cows in LN 3+ compared to LN 
1.  Recombinant bST was found to decrease pregnancy rates of lactating dairy cattle 
regardless of treatment.  The greatest decrease in pregnancy rates was detected for 
animals < 100 DIM and administered rBST.  More research is needed to maximize 
efficiency of FM as a PGF2α inhibitor during artificial insemination, and development of 
management practices to minimize the detrimental effects of rBST on reproductive 
performance during early lactation.        
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